Toggle light / dark theme

At a time when the world is scrambling to find a cure, a vaccine or some sort of viable treatment for the Novel Coronavirus that is rocking the globe, the Ethiopian Ministry of Health (MoH) and the Ministry of Innovation and Technology (MoIT) have disclosed that they have an effective treatment in the pipeline that enhances natural immunity in the fight againt the virus.

Although the details of the ingredients as well as the laboratory procedure and testing were not presented in detail, the two ministries said that a treatment drug has been discovered from the traditional medicines in the country.

The statement that the MoIT issued on March 27, 2020, indicated that the medicine has passed the basic research procedures and was successful in the laboratory modeling processes.

Li Wenliang, the doctor in China who raised early awareness of the new coronavirus, died of the virus in February at 34. His death was shocking not only because of his role in publicizing the developing epidemic but also — given that young people do not have a high risk of dying from Covid-19 — because of his age.

Is it possible that Dr. Li died because as a doctor who spent a lot of time around severely ill Covid-19 patients, he was infected with such a high dose? After all, though he was one of the first young health care workers to die after being exposed up close and frequently to the virus, he was unfortunately not the last.

The importance of viral dose is being overlooked in discussions of the coronavirus. As with any other poison, viruses are usually more dangerous in larger amounts. Small initial exposures tend to lead to mild or asymptomatic infections, while larger doses can be lethal.

In a joint press statement, the Ministry of Health (MoH) and the Ministry of Innovation and Technology (MoIT) said: “a domestic treatment drug” is being developed by the traditional medicine experts of the country.

The two ministries said the drug was prepared by integrating indigenous traditional medical knowledge with modern science.


The Country says it is developing a cure for Covid-19.

Defining our “New Normal” in the Age of Coronavirus — Amanda Christensen, ideaXme (http://radioideaxme.com/) guest interviewer, interviews Ben Hammersley, one of the world’s leading futurists to answer questions about how we are going to work, live, thrive, and innovate in the coming years — #Ideaxme #BenHammersley #Innovation #Futurist #Futurism #Covid19 #Coronavirus #Science #Longevity #Health #Medicine #Environment #Space #Oceans #Literature #Music #Food #Future #Entertainment #Sports #Fashion Awesome Foundation European University Institute United Nations Alliance of Civilizations (UNAOC) UNAOC Fellowship Program Goldsmiths, University of London WIRED UK The Brookings Institution European Commission.


Amanda Christensen, ideaXme guest interviewer, interviews Ben Hammersley, one of the world’s leading futurists and founder of international Strategic Foresight agency Hammersley Futures.

Amanda Christensen Comments:

Our world as we know it has seemingly changed overnight as countries globally make the decision to impose lockdown-type mandates in a worldwide effort to slow the spread of the deadly coronavirus (Covid-19).

As statistics, mandates, stocks, and all information related to coronavirus changes minute by minute, it can be overwhelming to keep up with it all, let alone separate fact from fiction, with misinformation being spread just as rapidly as the virus itself.

The 19 3D-printable parts that make up the mask are visible on the Maker Mask website along with details on materials needed, download instructions, videos, the ability to donate to the cause and more. The cost of each finished mask, printed in about three hours, is estimated to be between $2 and $3.


A technology veteran and a 3D-printing “savant” have teamed with other members of industry, health care and government to launch Maker Mask, a Seattle nonprofit creating medically endorsed, reusable protective masks using everyday 3D printers.

Jonathan Roberts, founder and partner at the Bellevue, Wash.-based venture capital firm Ignition Partners, is also a co-founder of RPrime, a nonprofit that is helping to fund the mask-making initiative. The former Microsoft executive said the goal is to address critical supply shortages and support “the real heroes on the front lines” of the COVID-19 pandemic.

The respirator-style mask with a replaceable HEPA filter and other commonly available parts, was developed by Rory Larson, a rapid prototyping expert with 10 years experience in engineering, CAD, 3D printing, CNC and small batch production manufacturing. It took just a week for the group, working with Larson’s design, to get a small production facility up and running out of Epiphany Parish in Seattle.

The newly emergent human virus SARS-CoV-2 is resulting in high fatality rates and incapacitated health systems. Preventing further transmission is a priority. We analyzed key parameters of epidemic spread to estimate the contribution of different transmission routes and determine requirements for case isolation and contact-tracing needed to stop the epidemic. We conclude that viral spread is too fast to be contained by manual contact tracing, but could be controlled if this process was faster, more efficient and happened at scale. A contact-tracing App which builds a memory of proximity contacts and immediately notifies contacts of positive cases can achieve epidemic control if used by enough people. By targeting recommendations to only those at risk, epidemics could be contained without need for mass quarantines (‘lock-downs’) that are harmful to society. We discuss the ethical requirements for an intervention of this kind.

COVID-19 is a rapidly spreading infectious disease caused by the novel coronavirus SARS-COV-2, a betacoronavirus, which has now established a global pandemic. Around half of infected individuals become reported cases, and with intensive care support, the case fatality rate is approximately 2%. More concerning is that the proportion of cases requiring intensive care support is 5%, and patient management is complicated by requirements to use personal protective equipment and engage in complex decontamination procedures. Fatality rates are likely to be higher in populations older than in Hubei province (such as in Europe), and in low-income settings where critical care facilities are lacking. In the public health cost of failing to achieve sustained epidemic suppression was estimated as 250,000 lives lost in the next few months in Great Britain, and 1.1−1.2 million in the USA, even with the strongest possible mitigation action to ‘flatten the curve’.

Hospitals are threatening to fire health-care workers who publicize their working conditions during the coronavirus pandemic — and have in some cases followed through.

Ming Lin, an emergency room physician in Washington state, said he was told Friday he was out of a job because he’d given an interview to a newspaper about a Facebook post detailing what he believed to be inadequate protective equipment and testing. In Chicago, a nurse was fired after emailing colleagues that she wanted to wear a more protective mask while on duty. In New York, the NYU Langone Health system has warned employees they could be terminated if they talk to the media without authorization.